Glycine-based #tripeptide DT-109 reduces aortic and #coronary #atherosclerotic lesions and ameliorates #calcification in a nonhuman #PrimateModel, positioning it as a novel therapeutic agent for #CardiovascularDiseases. #medsky
Read in #STTT #OpenAccess: doi.org/10.1038/s413...
1
1
0
0